Beam Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Beam Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BEAM

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. 

CEO
John Evans
CEOJohn Evans
Employees
483
Employees483
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2017
Founded2017
Employees
483
Employees483

BEAM Key Statistics

Market cap
2.73B
Market cap2.73B
Price-Earnings ratio
-5.57
Price-Earnings ratio-5.57
Dividend yield
Dividend yield
Average volume
1.93M
Average volume1.93M
High today
$27.56
High today$27.56
Low today
$25.08
Low today$25.08
Open price
$25.27
Open price$25.27
Volume
1.95M
Volume1.95M
52 Week high
$35.25
52 Week high$35.25
52 Week low
$13.53
52 Week low$13.53

Analyst ratings

87%

of 15 ratings
Buy
86.7%
Hold
13.3%
Sell
0%

People also own

Based on the portfolios of people who own BEAM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.